ApoE4, the strongest genetic risk factor for late-onset AD, provides insights into genetic risk, aiding in the identification of individuals with elevated or reduced risk and complementing other biomarkers in stratifying amyloid pathology [13]. This evidence concerns the gene APOE and Alzheimer disease.